[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355661-105":59,"doc-detail-355661-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","stage-dependent-changes-in-kynurenine-pathway-enzyme-expression-suggest-immune-related-involvement-in-bladder-cancer-progression","Stage-Dependent Changes in Kynurenine Pathway Enzyme Expression Suggest Immune-Related Involvement in Bladder Cancer Progression","","L-tryptophan metabolism through the L-kynurenine pathway drives immune escape in neoplasms, including bladder cancer. Indoleamine 2,3-dioxygenase-1 (IDO1) and its catabolites regulate immunomodulation, motivating an evaluation of how Kyn-pathway enzyme expression links to bladder cancer prognostic factors. Analyses of 165 patients from GEO DataSets correlated staging, grade, progression, and recurrence with IDO1 and related enzymes. In bladder cancer cell lines, IFN-gamma induced distinct enzyme patterns that were blocked by an IDO1 inhibitor, while high Trp consumption altered downstream catabolites.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/stage-dependent-changes-in-kynurenine-pathway-enzyme-expression-suggest-immune-related-involvement-in-bladder-cancer-progression/355661/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/stage-dependent-changes-in-kynurenine-pathway-enzyme-expression-suggest-immune-related-involvement-in-bladder-cancer-progression/355661.png","ImageObject",300,407,{"name":92,"@type":93},"Aditya","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main biological pathway studied in this article?","Question",{"text":113,"@type":114},"The study focuses on L-tryptophan metabolism through the L-kynurenine (Kyn) pathway, emphasizing IDO1 and downstream catabolites involved in immunomodulation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were patient and clinical associations evaluated?",{"text":118,"@type":114},"Data from 165 bladder cancer patients in GEO DataSets were analyzed, comparing staging, tumor grade, progression, and recurrence with expression of multiple Kyn-pathway enzymes.",{"name":120,"@type":111,"acceptedAnswer":121},"What effect did IFN-gamma and the IDO1 inhibitor have in bladder cancer cells?",{"text":122,"@type":114},"In RT4 and T24 cells, IFN-gamma increased IDO1 and KYNU while decreasing KAT and KMO in the more invasive T24 line; these changes were inhibited by INCB024360.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355661,1790185707,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","International Journal of Urology  \n ORIGINAL ARTICLE  OPEN ACCESS   \nLaboratory Investigation  \nStage-Dependent Changes in Kynurenine Pathway Enzyme Expression Suggest Immune-Related Involvement in Bladder Cancer Progression  \nDouglas Edgard Lemes1  | Aline Áurea de Souza Santos1  | Jéssica Lopes de Oliveira1  | Henrique Roman-Ramos1  | Ana Carolina Ramos Moreno2,3  | Cleber Pinto Camacho1,4  | José Pontes-Junior5  | Humberto Dellê1   \n1Molecular Innovation and Biotechnology Laboratory, Postgraduate Program in Medicine, Universidade Nove de Julho (Uninove), São Paulo, SP, Brazil | 2Vaccine Development Laboratory, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP,  \nBrazil | 3Vaccine Development Laboratory, Butantan Institute, São Paulo, SP, Brazil | 4Thyroid Diseases Center, Laboratory of Molecular and Translational Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP,  \nBrazil | 5Urology Department, LIM/55-Laboratory of urology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo, São Paulo, SP, Brazil  \nCorrespondence: Humberto Dellê ([phdelle@gmail.com](phdelle@gmail.com))  \nReceived: 30 April 2025 | Revised: 9 December 2025 | Accepted: 20 April 2026  \nKeywords: bladder cancer | immuno escape | indoleamine 2,3-dioxygenase-1 | kynurenine | tryptophan  \nABSTRACT  \nL-tryptophan (Trp) metabolism through the L-kynurenine (Kyn) pathway contributes to immune escape in neoplasms, including bladder cancer (BC) . Indoleamine 2,3-dioxygenase-1 (IDO1) is a key enzyme, and its catabolites—Kyn, 3-hydroxykynurenine (3HK), and 3-hydroxyanthranilate (3HAA)—depend on other enzymes and play a crucial role in immunomodulation. Objectives: We investigated the association between Kyn pathway enzyme expression and BC prognostic factors.  \nMethods: Data from 165 bc patients in the GEO DataSets were analyzed, comparing staging, tumor grade, progression, and recurrence with the expression of IDO1, arylformamidase (AFMID), kynurenine–oxoglutarate transaminase (KAT), kynureninase (KYNU), kynurenine 3-monooxygenase (KMO), 3-hydroxyanthranilate 3,4-dioxygenase (HAAO), and aminocarboxymuconatesemialdehyde decarboxylase (ACMSD). Predictive genes were further evaluated in RT4 (low-grade, non-invasive) and T24 (highgrade, invasive) BC cells treated with IFN-gamma and the IDO1 inhibitor INCB024360. Trp catabolites were quantified in the supernatant.  \nResults: Enzyme expression varied widely, especially for IDO1, AFMID, KAT, KMO, and KYNU. IDO1 correlated positively with KMO and negatively with KAT. High IDO1 and KMO levels were linked to advanced-stage disease, while KAT and KYNU were associated with earlier stages and lower tumor grade. RT4 and T24 cells showed distinct basal enzyme expression, with T24 cells being more responsive to IFN-gamma, increasing IDO1 and KYNU while decreasing KAT and KMO. These effects were inhibited by INCB024360. High Trp consumption increased Kyn and 3HAA but not 3HK.  \nConclusions: Kyn pathway enzyme expression varies with disease progression and may indicate immune activity by influencing tumor microenvironment catabolites. BC cell sensitivity to immune stimuli differs, potentially shaping distinct immune escape mechanisms.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). International Journal of Urology published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Urological Association.  \nInternational Journal of Urology, 2026; 33:e70491 1 of 11  \n[https://doi.org/10.1111/iju.70491](https://doi.org/10.1111/iju.70491)  \n1 | Introduction  \nBladder cancer (BC) is the fourth most common malignancy in men, wit","cbCaihOxqmzMwsjs","https://ap.wps.com/l/cbCaihOxqmzMwsjs","pdf",1356530,"English","# Introduction\n# L-tryptophan catabolism and immune evasion\n## IDO1 inhibition and trial outcomes\n## Challenges in assessing Kyn pathway status\n# Methods and analysis\n## Patient datasets and gene comparisons\n## Cell line treatments and quantification\n# Results\n# Conclusions","[{\"question\":\"What is the main biological pathway studied in this article?\",\"answer\":\"The study focuses on L-tryptophan metabolism through the L-kynurenine (Kyn) pathway, emphasizing IDO1 and downstream catabolites involved in immunomodulation.\"},{\"question\":\"How were patient and clinical associations evaluated?\",\"answer\":\"Data from 165 bladder cancer patients in GEO DataSets were analyzed, comparing staging, tumor grade, progression, and recurrence with expression of multiple Kyn-pathway enzymes.\"},{\"question\":\"What effect did IFN-gamma and the IDO1 inhibitor have in bladder cancer cells?\",\"answer\":\"In RT4 and T24 cells, IFN-gamma increased IDO1 and KYNU while decreasing KAT and KMO in the more invasive T24 line; these changes were inhibited by INCB024360.\"}]","Stage-Dependent Changes in Kynurenine Pathway Enzyme Expression Suggest Immune-Related Involvement in Bladder Cancer Progression | PDF",1790120395,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7be381377fd619ed9b79427a7c928cc.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3ef8d48d607fa05467da1290a58ce63.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bf9e298b269db6d8963c634a3b349be.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b3988a7f3416726eb3621acf316fd6f.webp",980,1287]